Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease

P Sestini, E Renzoni, S Robinson… - Cochrane Database …, 1996 - cochranelibrary.com
Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a chronic condition
characterised by progressive airflow limitation that is at most partially reversible. Despite the …

Routine nebulized ipratropium and albuterol together are better than either alone in COPD

COMBIVENT Inhalation Solution Study Group - Chest, 1997 - Elsevier
Study objective We compared the long-term safety and efficacy of the combination
ipratropium bromide (IB) and albuterol sulfate (ALB) inhalation solution with that of each …

A review of ipratropium bromide/fenoterol hydrobromide (Berodual®) delivered via Respimat® Soft Mist™ Inhaler in patients with asthma and chronic obstructive …

F Kässner, R Hodder, ED Bateman - Drugs, 2004 - Springer
Asthma and chronic obstructive pulmonary disease (COPD) can be effectively treated by the
use of bronchodilator therapies delivered by inhalation. Berodual® is a fixed combination of …

The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy

J Congleton, MF Muers - Respiratory medicine, 1995 - Elsevier
Breathlessness is a common symptom in patients with primary bronchial carcinoma and is
often not well-controlled. Most patients are ex-or current smokers, and therefore are at high …

Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.

P Moayyedi, J Congleton, RL Page, SB Pearson… - Thorax, 1995 - thorax.bmj.com
BACKGROUND--Patients admitted with acute exacerbation of chronic obstructive pulmonary
disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 …

Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease

SK Barta, A Crawford, CM Roberts - Respiratory medicine, 2002 - Elsevier
There is some controversy amongst respiratory physicians over the value of domiciliary
nebuliser use for chronic lung conditions. Most recommendations for assessment of …

[HTML][HTML] Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

NJ Gross, HS Nelson, RJ Lapidus, L Dunn, L Lynn… - Respiratory …, 2008 - Elsevier
Nebulized solutions of long-acting bronchodilators provide an alternative to DPI and MDI
delivery, particularly for COPD patients unable to use hand-held devices easily or correctly …

Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease

GL Colice - The American journal of medicine, 1996 - Elsevier
The bronchodilator efficacy, safety, and persistence of effect of the anticholinergic agent
ipratropium bromide and the β-adrenergic agonist albuterol, both given by nebulization …

A long-term study of symptoms, spirometry and survival amongst home nebulizer users

BR O'driscoll, A Bernstein - Respiratory medicine, 1996 - Elsevier
Although home nebulizers are widely used to deliver bronchodilator medication to patients
with asthma and chronic obstructive pulmonary disease (COPD), the long-term benefits and …

Nebulisers for chronic obstructive pulmonary disease

BR O'Driscoll - Thorax, 1997 - ncbi.nlm.nih.gov
Definition of chronic obstructive generally agreed that the bronchodilation ob-pulmonary
disease tained is largely a reflection of the dose of In this paper the term “chronic obstructive …